Skip to main content
. 2019 Dec 10;10(65):6981–6996. doi: 10.18632/oncotarget.27363

Table 2. Real-time IC50 (µM) concentrations with single agent treatments (xCeLLigence real-time cell sensoring).

OVSAHO KURAMOCHI CAOV3
72 hr 168 hr 72 hr 168 hr 72 hr 168 hr
Carboplatin 42.1 ± 8.4 12.4 ± 4.5 37.2 ± 7.4 13.7 ± 3.3 36.3 ± 9.4 16.7 ± 2.4
Olaparib 33.6 ± 10.1 9.9 ± 3.3 36.8 ± 3.4 9.8 ± 1.2 23.1 ± 7.6 17.6 ± 1.1
LY294002 6.9 ± 3.6 5 ± 0.2 8.7 ± 1.1 7.4 ± 0.4 7 ± 1.4 6.1 ± 0.3
Crizotinib 6 ± 1.8 6.5 ± 2.0 6.8 ± 0.4 7.6 ± 0.6 6.9 ± 1.1 6.1 ± 0.9
Niraparib 29.9 ± 2.2 13.3 ± 1.4 25.7 ± 6.2 14.6 ± 1.8 23.1 ± 0.3 9.6 ± 1.2